What you can expect from an article on dizpharm.org: who writes it, who checks it, how it is dated and sourced, and how to get a mistake fixed.
Dizpharm Nigeria Limited · KM 10 Ibusa–Asaba Expressway, Delta State
Clinical and regulatory review of every article is carried out by the company's Superintendent Pharmacist, the pharmacist registered with the Pharmacists Council of Nigeria as responsible for the premises.
Articles are written by the Dizpharm editorial team — people who price cartons, register products with NAFDAC and ship to distributors. Where an article gives a figure, it comes from our own price list, our own plant, or a named public source.
Any article that touches dosing, indications, drug classes, prescription status or NAFDAC/PCN rules is checked by the Superintendent Pharmacist before publication and again when it is materially updated. The reviewer's name appears in the byline when one is on record.
Every article shows a published date and, when revised, an updated date. Price guides also show the month the figures were last verified, because naira prices move.
Regulatory statements link to the NAFDAC, PCN or CAC page they rest on. Product claims link to the NAFDAC Greenbook entry. We do not cite ourselves as the authority for a rule.
Dizpharm manufactures paracetamol, ibuprofen, diclofenac, metronidazole, co-trimoxazole, ciprofloxacin, vitamins and Chrismatel water. Where an article mentions our products, it says so, and competitor brands are named neutrally.
If something is wrong, out of date or unclear, tell us and we will fix it and note the change. WhatsApp +234 818 749 4741 or email info@dizpharm.org.
Company figures behind the articles are published, dated and sourced on the statistics page. Product registrations can be checked on each product page's "Verify this product" section and on the NAFDAC Greenbook. Browse the distribution blog.
